Powder: -20°C for 3 years
In solvent: -80°C for 2 years
Pioglitazone is an insulin sensitizing agent and thiazolidinedione that is indicated for the treatment of type 2 diabetes. Pioglitazone has been linked to rare instances of acute liver injury.
Description | Pioglitazone is an insulin sensitizing agent and thiazolidinedione that is indicated for the treatment of type 2 diabetes. Pioglitazone has been linked to rare instances of acute liver injury. |
Targets&IC50 | human PPARγ:0.93 μM (EC50), mouse PPARγ:0.99 μM (EC50) |
Synonyms | 匹格列酮, U 72107, 吡格列酮 |
Molecular Weight | 356.44 |
Formula | C19H20N2O3S |
CAS No. | 111025-46-8 |
Powder: -20°C for 3 years
In solvent: -80°C for 2 years
DMSO: 15 mg/mL (42.08 mM)
Ethanol: <1 mg/mL
H2O: <1 mg/mL
( < 1 mg/ml refers to the product slightly soluble or insoluble )
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Pioglitazone 111025-46-8 DNA损伤和修复 代谢 凋亡 细胞周期 Ferroptosis PPAR Peroxisome proliferator-activated receptors diabete domain PPARγ inhibit U 72107 U-72107 blood glucose ligand-binding Inhibitor U72107 inhibitor